The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 30, 2024
Filed:
Mar. 08, 2023
Applicant:
Azura Ophthalmics Ltd., Tel Aviv, IL;
Inventors:
Yair Alster, Tel Aviv, IL;
Omer Rafaeli, Udim, IL;
Kirsten Angela MacFarlane, Menlo Park, CA (US);
Cary Reich, Santa Barbara, CA (US);
Shimon Amselem, Rehovot, IL;
Doron Friedman, Carme-Yosef, IL;
Assignee:
AZURA OPHTHALMICS LTD., Tel Aviv, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/60 (2006.01); A61K 8/22 (2006.01); A61K 8/23 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/122 (2006.01); A61K 31/17 (2006.01); A61K 31/19 (2006.01); A61K 31/327 (2006.01); A61K 31/4015 (2006.01); A61K 31/555 (2006.01); A61K 33/04 (2006.01); A61K 35/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/60 (2013.01); A61K 8/22 (2013.01); A61K 8/23 (2013.01); A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 31/122 (2013.01); A61K 31/17 (2013.01); A61K 31/19 (2013.01); A61K 31/327 (2013.01); A61K 31/4015 (2013.01); A61K 31/555 (2013.01); A61K 33/04 (2013.01); A61K 35/04 (2013.01); A61K 9/0014 (2013.01);
Abstract
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction.